Drugs in the GLP-1 agonist class such as Ozempic and Wegovy have already transformed diabetes and obesity treatment, and now researchers say that they may also help prevent certain types of cancer. According to National Public Radio, early studies have already shown the drug's promise against several common cancers, including those linked with excess weight and obesity (such as breast, colon, and liver).
Rick Good spent ten years in the newspaper business, including with The News & Observer (Raleigh, NC) and The Greenville News (Greenville, SC). He co-wrote, with Melinda Coleman, Rutledge to Riley: Governors of South Carolina, 1776–Present (Published by The Greenville News), and is the author of Mind Games Trivia #1 (Amazon). He has recently spent 15 years creating original trivia content through Sounds Good Mobile Entertainment and continues that with his new company, SGME Software. He edits The Smart Reader’s money, real estate, and business coverage.
